Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms

Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
Conditions:   Myeloid Malignancy;   Myelodysplastic Syndromes;   Myelofibrosis;   Acute Myeloid Leukemia;   Myeloproliferative Neoplasm
Interventions:   Drug: Navitoclax;   Drug: Venetoclax;   Drug: Decitabine
Sponsors:   Jacqueline Garcia, MD;   AbbVie
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 23, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments